HIBAPRESS
The Nobel Committee in Medicine was unable to inform the American scientist Fred Ramsdell of his Nobel Prize win for 2025, after he chose to spend his days on a long hike in the embrace of nature, far from communication networks and technology.
The Royal Swedish Academy of Sciences awarded the prize to Fred Ramsdell and Marie E. Bronko from the United States, and Shimon Sakaguchi from Japan, in recognition of their discoveries related to how the body controls its immune system, specifically in what is known as peripheral immune tolerance.
A spokesperson for Sonoma Biotherapeutics, a biotechnology company in San Francisco, where Ramsdell works, said that the latter "is completely out of touch and enjoying his time in nature," which prevented the committee from contacting him to inform him of his win.
Jeffrey Bluestone, one of the company's founders and a friend of the American scientist, confirmed that he tried to contact him to no avail, adding: "It seems he is wandering in the remote rural areas of Idaho."
The committee also faced difficulty in contacting researcher Marie Bronko, who resides on the American West Coast, due to the time difference with the Swedish capital Stockholm, but later managed to reach her.
Thomas Perlmann, the Secretary-General of the prize committee, explained that he asked Ramsdell and Bronko to call him back "whenever they can."
The Nobel Committee indicated that the three winners discovered regulatory T cells, or what is known as the "guardian cells" of the immune system, which prevent immune cells from attacking the body's own tissues.
The committee added that this discovery established a new research field and contributed to the development of innovative treatments against cancer and autoimmune diseases.
